CHOICE-ICD

• Research type

  Research Study

• Full title

  To co-develop and test an eHealth intervention to improve knowledge, attitude and experience in patients living with an Implantable Cardioverter Defibrillator

• IRAS ID

  339344

• Contact name

  Loreena/LM Hill

• Contact email

  l.hill@qub.ac.uk

• Sponsor organisation

  Queen's University, Belfast

• Duration of Study in the UK

  1 years, 10 months, 4 days

• Research summary

  The role of the implantable cardioverter defibrillator (ICD) is to monitor heart rate and discharge a small electrical discharge or shock if the heart rate becomes life threatening. Previous studies have found that patients and family members have requested more information about their ICD, how it works and how to live well with the device. This study will build on this evidence by designing, in collaboration with patients, family members and professionals (PPI), an online resource (APP) to provide up to date information to reduce anxiety and improve quality of life.
  The CHOICE-ICD APP will be easy to use, incorporating quizzes to encourage engagement, up to date information on the ICD appropriate to each patient's needs, day to day practical advice, as well as animation clips, virtual reality, and short patient videos. A total of 128 patients will be randomized to receive the intervention (Choice-ICD and BHF booklet) or usual care (BHF booklet).
  The CHOICE-ICD APP will be made available to 64 patients awaiting or with a recently implanted ICD in Belfast and Clydebank. Patients will use the APP for 3 months. Patients and family members will then be asked to complete questionnaires and invited to share their thoughts on i.e. how well the intervention worked and if they would use it again. Data will also be downloaded from the APP, to determine user engagement, for example the topics most viewed

• REC name

  HSC REC B

• REC reference

  24/NI/0044

• Date of REC Opinion

  19 Apr 2024

• REC opinion

  Unfavourable Opinion